Issue link: https://www.e-digitaleditions.com/i/1463386
34 April 2022 Inhalation Nasal formulation development and manufacturing Renaissance Lakewood offers contract development and manufacturing for nasal sprays. We can support all stages of projects, from formulation development through commercial manufacturing. With over 20 years of experience, our team can support a wide range of development activities including formulation development/optimization, spray method develop- ment, device selection, clinical trial material, process development and stability studies. In addition, we can support a wide range of nasal spray devices, includ- ing unit-dose, bi-dose and multi-dose (preserved and non-preserved formulations). Renaissance Lakewood US: +1 732 367-9000 www.renpharm.com Bespoke inhaled formulation development i2c Pharmaceutical Services is a leading independent service provider to global pharma, medical technol- ogy and emerging companies for the development of inhaled formulations and efficient devices. i2c provides bespoke integrated services from ab initio development through clinical trials. i2c also offers Respitab ® ; this propellant-dispersible tablet is a cost-effective and innovative manufacturing platform that can facilitate transition to the next generation of pressurized metered dose inhalers (pMDIs). i2c Pharmaceutical Services UK: +44 2920 757865 www.i2cpharm.co.uk End-to-end service Recipharm offers end-to-end service from early devel- opment to commercial manufacturing for MDIs, DPIs and nasal sprays. Delivering market leading design, development and manufacturing of drug delivery devices to the global market in conjunction with Bespak by Recipharm, the integrated CDMO can comprehensively cater to inhaler and nasal proj- ects. Recipharm also provides access to a team of experts with decades of expertise that allows them to manage complexity and accelerate routes to market. is expertise forms part of Recipharm's Inhalation Solutions™, an end-to-end solution spanning early phase development to commercial manufacture. Recipharm Sweden: +46 8 602 52 00 www.recipharm.com Integrated, end-to-end services Hovione offers end-to-end service for particle-based and inhalation products. With more than 20 years of expertise in the development and marketing of inno- vative inhalation devices, we offer dry powder inhalers that are simple, patented and cost-effective. Crystalli- zation, jet milling and wet milling spray-drying pro- cesses are developed using a quality by design (QbD) approach to deliver the physical, chemical and micro- biological critical quality attributes of the active phar- maceutical ingredient. Hovione also offers a complete portfolio of platforms suitable for both innovator and generic development. Hovione Portugal: +351 21 982 9000 www.hovione.com